Promoting Early Intervention Timing and Attention to Language
NCT ID: NCT05853861
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
140 participants
INTERVENTIONAL
2024-11-25
2028-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Children will be recruited at 6-8 months of age and will begin with entry assessments. All children will first begin with the MONITOR condition (using Ages \& Stages Questionnaire (ASQ-3) and activity cards. Then when the child is 9 months, they will be randomized to continue with MONITOR condition or COACH condition (incorporates JASPER intervention and Babble Bootcamp) after second set of assessments. There are a total of 6 assessment timepoints (6-8 months of age, 9 months of age, 12 months of age, 15 months of age, 18 months of age, and 24 months of age). At time points of 9months and 12 months, the child will be randomized to COACH or MONITOR conditions. Once the child is randomized to COACH condition, they will continue with that condition until they terminate the study at 24 months. At the 15 months timepoint, there will no longer be a randomization. Children that were in the MONITOR condition will change to the COACH condition until they terminate the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Training Early Social Language in Autism
NCT03427138
Boosting Language Outcomes of Minimally Verbal Children With ASD (BLOOM)
NCT04218331
Combination Treatment for Augmenting Language in Children With ASD
NCT02574741
Word Learning in Children With Autism
NCT03419611
Study of Toddlers With Language Delay
NCT01339767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will use a four phase, Sequential Multiple Assignment Randomized Trial (SMART) design to examine theeffectiveness of transitioning to more intensive early intervention prior to 15 months of age, and to inform clinical decision-making concerning the optimal time to transition to more intensive intervention based on the specific characteristics of thechild. Phase 1 begins at age 6 months; after baseline demographic, language, behavior and brain assessments, allchildren are offered the MONITOR intervention. Phase 2 begins at age 9 months; after language, behavior and brainassessments, all children are randomly assigned to transition to MONITOR plus COACH (with probability 1/3) versuscontinue with MONITOR (with probability 2/3). Phase 3 begins at age 12 months; following language, behavior, and brainassessments, children who have not yet transitioned to MONITOR plus COACH are randomly assigned (with equalprobability) to transition to MONITOR plus COACH versus continue with MONITOR. Phase 4 begins at age 15 months;following language and behavior assessments, all remaining children will transition to MONITOR plus COACH.
The MONITOR condition consists will take a global, general domain approach to providing parents with information totrack the early development of their infants, along with specific developmentally targeted activities. The well validatedAges and Stages-3+ screening tool along with activity cards will provide information to parents at each age. All parentswill receive these materials at 3-month intervals, along with a developmentally chosen toy and book for their infant. Wewill provide an appropriate toy/book given we expect a diverse sample including many low resourced families. Thequestionnaire takes 10- 15 minutes to complete and covers developmental domains of communication, motor, problem-solving and personal-social, and is available in English, Spanish, and several other languages. We will drop off or mail thespecific form and activity card (plus toy and book) to families at each of our specified ages---6, 9, 12, 15, 18, 21 and 24months. The intervention activities card includes suggestions for games and other fun events for parent- infant dyads.Moreover, each family will have access to the intervention team (text, call, zoom) on an as needed protocol, and we willkeep track of all contact. The MONITOR intervention continues for all infants and parents throughout the study periodeven after receiving COACH intervention.
The COACH condition consists of a blended intervention of two evidence tested interventions, JASPER and BabbleBootcamp Infant-parent dyads will be randomized to receive COACH (JASPER Babble) at 9, 12 or 15 months. JASPERBabble addresses early parent-child social communication by helping to close the 'feedback loop'. When parents talk andplay with their infant, the infant increases their developmental behaviors which serve to provide more opportunities forparents to respond. Babble Bootcamp targets on babbling specifically will be incorporated into this feedback loop, and theimportance of the blended intervention should be underscored, providing both context and targets. For infant-parentdyads randomized to COACH, we will set up once weekly remote (zoom) 1-hour coaching sessions in betweenassessment visits each 3 months. Similar to the ASQ-3+ monitoring intervention, parents will have access to theintervention team on as needed basis throughout the study if they request more input, and we will track this contact. Oncerandomized to COACH, parents will continue to receive the remotely delivered intervention throughout the study period.
Assessments will be administered at 6 timepoints. At entry (when child is 6-8 months), parents will sign consent, fill outdemographic forms, treatment history form, Mullen, PCX, LENA, and EEG.
At the 9 months and 12 months timepoints, the Mullen, PCX, LENA, and EEG will be administered again.
At 15, 18, and 24 months, the Mullen, PCX, LENA will be administered. An ADOS-2 will also be administered at 24months only.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MONITOR
Participants in this arm will be provided with information to track the early development of their infants, along with specific developmentally targeted activities.
No interventions assigned to this group
COACH
Participants will be provided with a blended intervention of two evidence tested intervention, JASPER and Babble Bootcamp along with continued monitoring.
JASPER
JASPER is an evidence based early intervention that focuses on the core social communication and engagement skills of young children that are important to improvements in communication and language.
Babble Bootcamp
Babble Bootcamp is a new intervention focusing on the speech-motor system and aims to improve babbling and early word use in infants known to be at risk for language delay.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
JASPER
JASPER is an evidence based early intervention that focuses on the core social communication and engagement skills of young children that are important to improvements in communication and language.
Babble Bootcamp
Babble Bootcamp is a new intervention focusing on the speech-motor system and aims to improve babbling and early word use in infants known to be at risk for language delay.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Both males and females are eligible for study participation and will be recruited.
* Family income is under the very low income described under the Department of Housing and Community DevelopmentDivision of Housing Policy Agreement for the city of Los Angeles.
Exclusion Criteria
* Infant is expected to have surgery over the next year
* Infant has associated physical disorders, and/or co-morbid with other syndromes or diseases.
* All of the children will be free of additional sensory or motor impairments (e.g., Visual or hearing impairment) and othergenetic syndromes (e.g., Down Syndrome).
* In addition, infants who are premature or less than 34 weeks (gestational age \<34 weeks) will be excluded.
6 Months
8 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Worcester
OTHER
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Connie Kasari, Ph.D.
Professor/PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA
Los Angeles, California, United States
University of Massachusetts Medical Center
Worcester, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Connie Kasari, PhD
Role: primary
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-001637
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.